These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14523939)

  • 21. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains.
    Tkachenko AG; Xie H; Liu Y; Coleman D; Ryan J; Glomm WR; Shipton MK; Franzen S; Feldheim DL
    Bioconjug Chem; 2004; 15(3):482-90. PubMed ID: 15149175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activity of Tat (47-58) peptide on human pathogenic fungi.
    Jung HJ; Park Y; Hahm KS; Lee DG
    Biochem Biophys Res Commun; 2006 Jun; 345(1):222-8. PubMed ID: 16678135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tat peptide mediated cellular uptake of SiO2 submicron particles.
    Mao Z; Wan L; Hu L; Ma L; Gao C
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):432-40. PubMed ID: 19846283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
    Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
    Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of HIV-Tat protein transduction domain.
    Yoon JS; Jung YT; Hong SK; Kim SH; Shin MC; Lee DG; Shin WS; Min WS; Paik SY
    J Microbiol; 2004 Dec; 42(4):328-35. PubMed ID: 15650690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.
    Shiraishi T; Pankratova S; Nielsen PE
    Chem Biol; 2005 Aug; 12(8):923-9. PubMed ID: 16125104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular cargo delivery using tat peptide and derivatives.
    Zhao M; Weissleder R
    Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B; To R; Stayton PS
    Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells.
    Huang L; Farhood H; Serbina N; Teepe AG; Barsoum J
    Biochem Biophys Res Commun; 1995 Dec; 217(3):761-8. PubMed ID: 8554596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells.
    Cardarelli F; Serresi M; Bizzarri R; Beltram F
    Traffic; 2008 Apr; 9(4):528-39. PubMed ID: 18182009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel Na+- and Cl--coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat.
    Hu H; Miyauchi S; Bridges CC; Smith SB; Ganapathy V
    Biochem J; 2003 Oct; 375(Pt 1):17-22. PubMed ID: 12924983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF; Murphy MP
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.
    Kawamura KS; Sung M; Bolewska-Pedyczak E; Gariépy J
    Biochemistry; 2006 Jan; 45(4):1116-27. PubMed ID: 16430208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
    Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-penetrating cis-gamma-amino-l-proline-derived peptides.
    Farrera-Sinfreu J; Giralt E; Castel S; Albericio F; Royo M
    J Am Chem Soc; 2005 Jul; 127(26):9459-68. PubMed ID: 15984873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.